Navacaprant, a Novel Kappa Opioid Receptor Antagonist for Major Depressive Disorder: A Randomized Placebo-Controlled Phase 2 Trial Sanjay Mathew,Andrew Cutler, Nicole Visitacion, Michael Gold, Jason Yuan, Bill AuroraBiological Psychiatry(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要